InflaRx NV buy Guggenheim
Start price
05.04.23
/
50%
€4.97
Target price
05.04.24
€7.32
Performance (%)
-71.61%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. Massive losses of -71.61% were the result for the BUY prediction by Guggenheim. Guggenheim has a follow-up prediction for InflaRx NV where he still thinks InflaRx NV is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InflaRx NV | -9.634% | -9.634% | -65.902% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten